Top Premarket Decliners

MT Newswires Live11-09

Zura Bio (ZURA) stock was 69% lower pre-bell Monday after the company said a phase 2 clinical trial of tibulizumab in adults with moderate-to-severe hidradenitis suppurativa failed to meet its primary endpoint.

Orthofix Medical (OFIX) shares were down 24% after the company reported its Q3 results and revised its 2026 guidance.

Sable Offshore (SOC) stock was 22% lower after the company posted its Q3 financial results.

Digital Brands Group (DBGI) shares were down 22%, extending the nearly 40% fall in Friday's session.

The Children's Place's (PLCE) stock was 22% lower after the company said it voluntarily filed for Chapter 11 bankruptcy protection.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment